13F filer · CIK 2012383 ↗

BlackRock

You are looking at Q1 2023. See the latest, Q2 2026 →

Reported value

$3.39T

+6.2% on the quarter before

Positions

5,562

184 new · 387 sold out

Top 10

19.4%

of the value

Est. gain

+$188.49B

on stocks held all quarter

Est. return

+6.0%

on those stocks since Q4 2022

Filed

May 12, 2023

On SEC EDGAR ↗

Positions as of Mar 31, 2023, from BlackRock's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

The 24 largest positions, 30% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2022. Striped tiles are options.

Apple5.0%Microsoft4.6%Amazon1.9%Nvidia1.5%Alphabet1.3%Alphabet1.1%Tesla1.1%
Unitedhealth Group Inc1.0%
Meta1.0%
Berkshire Hathaway Inc Del0.9%
Johnson & Johnson0.9%
Exxon Mobil Corp0.9%
Ishares Tr0.9%
Visa Inc.0.8%
Jpmorgan Chase & Co0.7%
Procter And Gamble Co0.7%
Mastercard0.7%
Home Depot Inc0.7%
Eli Lilly0.7%
Merck & Co Inc0.7%
Abbvie Inc0.7%
Chevron Corp New0.6%
Pepsico Inc0.6%
Coca Cola Co0.6%

Largest buys

Since Q4 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Linde Plc~$12.19BNew · 0.0% → 0.4%+34,287,378 shares
  2. GE HealthCare~$2.19BNew · 0.0% → 0.1%+26,748,133 shares
  3. Ishares TrPUT~$1.89BAdded · 0.0% → 0.1%+25,051,400 underlying
  4. Ishares TrPUT~$1.75BAdded · 0.0% → 0.1%+15,922,900 underlying
  5. Microsoft~$1.59BAdded · 4.0% → 4.6%+5,530,388 shares
  6. Amazon~$1.33BAdded · 1.6% → 1.9%+12,898,862 shares
  7. Nvidia~$1.07BAdded · 0.8% → 1.5%+3,869,285 shares
  8. Apple~$956.5MAdded · 4.2% → 5.0%+5,800,617 shares
  9. SPDR Gold TrCALL~$905.2MNew · 0.0% → 0.0%+4,940,400 underlying
  10. Paccar Inc~$804.6MAdded · 0.1% → 0.1%+10,991,638 shares

Largest sells

Since Q4 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Linde Plc~$10.28BSold out · 0.3% → 0.0%−31,518,988 shares
  2. Exxon Mobil Corp~$1.45BCut · 1.0% → 0.9%−13,228,555 shares
  3. Ishares Tr~$1.10BCut · 0.9% → 0.9%−2,668,990 shares
  4. Svb Financial Group~$1.10BSold out · 0.0% → 0.0%−4,764,351 shares
  5. Store Cap Corp~$935.7MSold out · 0.0% → 0.0%−29,184,862 shares
  6. Philip Morris Intl Inc~$756.2MCut · 0.3% → 0.3%−7,775,353 shares
  7. Lhc Group Inc~$748.0MSold out · 0.0% → 0.0%−4,625,841 shares
  8. South Jersey Inds Inc~$729.7MSold out · 0.0% → 0.0%−20,536,847 shares
  9. Conocophillips~$677.3MCut · 0.4% → 0.3%−6,827,255 shares
  10. Marathon Pete Corp~$656.2MCut · 0.2% → 0.2%−4,866,818 shares

Holdings

As of Mar 31, 2023. Changes are in shares against Dec 31, 2022, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
AppleCOM · shares +0.6% · price +26.9%5.0%$170.67B+$35.99B
MicrosoftCOM · shares +1.0% · price +20.2%4.6%$154.98B+$25.79B
AmazonCOM · shares +2.2% · price +23.0%1.9%$62.76B+$11.47B
NvidiaCOM · shares +2.2% · price +90.1%1.5%$51.02B+$23.67B
AlphabetCAP STK CL A · shares +1.6% · price +17.6%1.3%$43.82B+$6.45B
AlphabetCAP STK CL C · shares +0.3% · price +17.2%1.1%$38.06B+$5.57B
TeslaCOM · shares +0.5% · price +68.4%1.1%$37.07B+$14.98B
Unitedhealth Group IncCOM · shares +0.7% · price −10.9%1.0%$35.41B−$4.29B
MetaCL A · shares +0.8% · price +76.1%0.96%$32.41B+$13.90B
Berkshire Hathaway Inc DelCL B NEW · shares −0.9% · price −0.0%0.94%$31.99B−$13.5M
Johnson & JohnsonCOM · shares +1.4% · price −12.3%0.92%$31.23B−$4.30B
Exxon Mobil CorpCOM · shares −4.5% · price −0.6%0.90%$30.48B−$177.9M
Ishares TrCORE S&P500 ETF · shares −3.6% · price +7.0%0.86%$29.14B+$1.90B
Visa Inc.COM CL A · shares −0.9% · price +8.5%0.82%$27.92B+$2.19B
Jpmorgan Chase & CoCOM · shares −0.6% · price −2.8%0.75%$25.26B−$734.7M
Procter And Gamble CoCOM · shares +1.4% · price −1.9%0.71%$24.06B−$458.3M
MastercardCL A · shares +0.9% · price +4.5%0.70%$23.68B+$1.01B
Home Depot IncCOM · shares +1.2% · price −6.6%0.67%$22.76B−$1.58B
Eli LillyCOM · shares +0.8% · price −6.1%0.66%$22.52B−$1.46B
Merck & Co IncCOM · shares −2.6% · price −4.1%0.66%$22.25B−$953.5M
Abbvie IncCOM · shares +0.01% · price −1.4%0.65%$22.11B−$310.7M
Chevron Corp NewCOM · shares −1.1% · price −9.1%0.64%$21.84B−$2.19B
Pepsico IncCOM · shares −0.5% · price +0.9%0.59%$19.98B+$179.7M
Coca Cola CoCOM · shares +0.2% · price −2.5%0.57%$19.32B−$491.3M
BroadcomCOM · shares +1.7% · price +14.7%0.56%$19.15B+$2.42B
Total · 5,562 positions100%$3.39T+$188.49B
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q4 2022 to Q1 2023: 5,121 stocks held throughout, up $188.49B (+6.0%).

  1. Apple+$35.99B+27%
  2. Microsoft+$25.79B+20%
  3. Nvidia+$23.67B+90%
  4. Tesla+$14.98B+68%
  5. Meta+$13.90B+76%
  6. Chevron Corp New−$2.19B−9%
  7. Schwab Charles Corp−$3.25B−37%
  8. Unitedhealth Group Inc−$4.29B−11%
  9. Johnson & Johnson−$4.30B−12%
  10. Pfizer Inc−$4.62B−20%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 6 splits read into the share counts.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$8.00T$4.00T$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$6.73T+18%SEC ↗
Q1 2026$5.72T−3%SEC ↗
Q4 2025$5.92T+4%SEC ↗
Q3 2025$5.71T+9%SEC ↗
Q2 2025$5.25T+10%SEC ↗
Q1 2025$4.76T−4%SEC ↗
Q4 2024$4.94T+4%SEC ↗
Q3 2024$4.76T+8%SEC ↗
Q2 2024$4.42T+3%SEC ↗
Q1 2024$4.30T+10%SEC ↗
Q4 2023$3.92T+13%SEC ↗
Q3 2023$3.48T−4%SEC ↗
Q2 2023$3.63T+7%SEC ↗
Q1 2023$3.39T+6%SEC ↗
Q4 2022$3.19T+9%SEC ↗
Q3 2022$2.94T−6%SEC ↗
Q2 2022$3.12T−16%SEC ↗
Q1 2022$3.71T−6%SEC ↗
Q4 2021$3.93T+10%SEC ↗
Q3 2021$3.57T−1%SEC ↗
Q2 2021$3.59T+6%SEC ↗
Q1 2021$3.40T+9%SEC ↗
Q4 2020$3.13T+16%SEC ↗
Q3 2020$2.71T+8%SEC ↗
Q2 2020$2.51T+23%SEC ↗
Q1 2020$2.04T−22%SEC ↗
Q4 2019$2.61T+10%SEC ↗
Q3 2019$2.38T+2%SEC ↗
Q2 2019$2.34T+4%SEC ↗
Q1 2019$2.24T+13%SEC ↗
Q4 2018$1.98T−14%SEC ↗
Q3 2018$2.31T+6%SEC ↗
Q2 2018$2.17T+4%SEC ↗
Q1 2018$2.09T−0%SEC ↗
Q4 2017$2.10T+6%SEC ↗
Q3 2017$1.98T+5%SEC ↗
Q2 2017$1.89T+4%SEC ↗
Q1 2017$1.82T+2,478%SEC ↗
Q4 2016$70.66B+1%SEC ↗
Q3 2016$69.66B+5%SEC ↗
Q2 2016$66.46B+7%SEC ↗
Q1 2016$62.17BSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.